Inhibition of ERN1/IRE1α (endoplasmic reticulum to nucleus signaling 1/inositol requiring enzyme-1α), the major signaling pathway of endoplasmic reticulum stress, significantly decreases tumor growth. We have studied the expression of transcription factors such as E2F8 (E2F transcription factor 8), EPAS1 (endothelial PAS domain protein 1), TBX3 (T-box 3), ATF3 (activating transcription factor 3), FOXF1 (forkhead box F1), and HOXC6 (homeobox C6) in U87 glioma cells overexpressing dominant-negative ERN1/IRE1α defective in endoribonuclease (dnr-ERN1) as well as defective in both kinase and endonuclease (dn-ERN1) activity of ERN1/IRE1α. We have demonstrated that the expression of all studied genes is decreased at the mRNA level in cells with modified ERN1/IRE1α; TBX3, however, is increased in these cells as compared to control glioma cells. Changes in protein levels of E2F8, HOXC6, ATF3, and TBX3 corresponded to changes in mRNAs levels. We also found that two mutated ERN1/IRE1α have differential effects on the expression of studied transcripts. The presence of kinase and endonuclease deficient ERN1/IRE1α in glioma cells had a less profound effect on the expression of E2F8, HOXC6, and TBX3 genes than the blockade of the endoribonuclease activity of ERN1/IRE1α alone. Kinase and endonuclease deficient ERN1/IRE1α suppresses ATF3 and FOXF1 gene expressions, while inhibition of only endoribonuclease of ERN1/IRE1α leads to the up-regulation of these gene transcripts. The present study demonstrates that fine-tuning of the expression of proliferation related genes is regulated by ERN1/IRE1α an effector of endoplasmic reticulum stress. Inhibition of ERN1/IRE1α, especially its endoribonuclease activity, correlates with deregulation of proliferation related genes and thus slower tumor growth.
If the inline PDF is not rendering correctly, you can download the PDF file here.
 Zhang K, Kaufman RJ. The unfolded protein response: a stress
signaling pathway critical for health and disease. Neurology 2006;
66 (Suppl 1): S102–9.
 Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated
endoplasmic reticulum stress responses in cancer. Cancer Res
2007; 67: 10631–4.
 Wang S, Kaufman RJ. The impact of the unfolded protein response
on human disease. J Cell Biol 2012; 197: 857-67.
 Schröder M. Endoplasmic reticulum stress responses. Cell Mol Life
Sci 2008 65: 862–94.
 Malhotra JD, Kaufman RJ. ER stress and its functional link to
mitochondria: role in cell survival and death. Cold Spring Harb
Perspect Biol 2011; 3: a004424.
 Lenihan CR, Taylor CT. The impact of hypoxia on cell death
pathways. Biochem Soc Trans 2013; 41: 657–63.
 Minchenko OH, Kharkova AP, Bakalets TV, Kryvdiuk IV. Endoplasmic
reticulum stress, its sensor and signaling systems and the role in
the regulation of gene expressions in malignant tumor growth and
hypoxia. Ukr Biochem J 2013; 85(5): 5–16.
 Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. Regulated
Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell
Biol 2009; 186: 323–31.
 Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C,
Lennon CJ, Kluger Y, Dynlacht DD. XBP1 controls diverse cell
type- and condition-specific transcriptional regulatory networks.
Molecular Cell 2007; 27: 53–66.
 Aragón T, van Anken E, Pincus D., Serafimova IM, Korennykh AV,
Rubio CA, Walter P. Messenger RNA targeting to endoplasmic
reticulum stress signalling sites. Nature. 2009; 457: 736–40.
 Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa
A, Delugin M, Combe C, Loriot S, Cubel G, Dugot-Senant N, Vital A,
Loiseau H, Gosline SJ, Taouji S, Hallett M, Sarkaria JN, Anderson
K, Wu W, Rodriguez FJ, Rosenbaum J, Saltel F, Fernandez-Zapico
ME, Chevet E. Posttranscriptional regulation of PER1 underlies the
oncogenic function of IREα. Cancer Res. 2013; 73: 4732–43.
 Minchenko OH, Kubaichuk KI, Minchenko DO, Kovalevska OV,
Kulinich AO, Lypova NM. Molecular mechanisms of ERN1-mediated
angiogenesis. Int J Physiol Pathophysiol 2014; 5: 1-22.
 Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R,
Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A, Moenner M. IRE1
signaling is essential for ischemia-induced vascular endothelial
growth factor-A expression and contributes to angiogenesis and
tumor growth in vivo. Cancer Res 2007; 67: 6700–7.
 Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh
M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A,
Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. Inositolrequiring
enzyme 1alpha is a key regulator of angiogenesis and
invasion in malignant glioma. Proc Natl Acad Sci USA 2010; 107:
 Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, Platonova
N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko
D, Minchenko O, Moenner M. High epiregulin expression in human
U87 glioma cells relies on IRE1alpha and promotes autocrine growth
through EGF receptor. BMC Cancer 2013; 13: 597.
 Washkowitz AJ, Gavrilov S, Begum S, Papaioannou VE. Diverse
functional networks of Tbx3 in development and disease. Wiley
Interdiscip Rev Syst Biol Med 2012; 4: 273-83.
 Deng Q, Wang Q, Zong WY, Zheng DL, Wen YX, Wang KS, Teng XM,
Zhang X, Huang J, Han ZG. E2F8 contributes to human hepatocellular
carcinoma via regulating cell proliferation. Cancer Res 2010;
 Liu J, Edagawa M, Goshima H, Inoue M, Yagita H, Liu Z, Kitajima S
Role of ATF3 in synergistic cancer cell killing by a combination of
HDAC inhibitors and agonistic anti-DR5 antibody through ER stress
in human colon cancer cells. Biochem Biophys Res Commun 2014;
 Raspaglio G, Petrillo M, Martinelli E, Li Puma DD, Mariani M, De
Donato M, Filippetti F, Mozzetti S, Prislei S, Zannoni GF, Scambia
G, Ferlini C. Sox9 and Hif-2α regulate TUBB3 gene expression and
affect ovarian cancer aggressiveness. Gene 2014; 542: 173-81.
 Rizzardi AE, Rosener NK, Koopmeiners JS, Isaksson Vogel R,
Metzger GJ, Forster CL, Marston LO, Tiffany JR, McCarthy JB, Turley
EA, Warlick CA, Henriksen JC, Schmechel SC. Evaluation of protein
biomarkers of prostate cancer aggressiveness. BMC Cancer 2014;
 Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer
genetics and genomics of human FOX family genes. Cancer Lett
2013; 328: 198-206.
 Weijts BG, Bakker WJ, Cornelissen PW, Liang KH, Schaftenaar FH,
Westendorp B, de Wolf CA, Paciejewska M, Scheele CL, Kent L,
Leone G, Schulte-Merker S, de Bruin A. E2F7 and E2F8 promote
angiogenesis through transcriptional activation of VEGFA in
cooperation with HIF1. EMBO J 2012; 31: 3871-84.
 Christensen J, Cloos P, Toftegaard U, Klinkenberg D, Bracken AP,
Trinh E, Heeran M, Di Stefano L, Helin K. Characterization of E2F8,
a novel E2F-like cell-cycle regulated repressor of E2F-activated
transcription. Nucl Acids Res 2005; 33: 5458-70.
 Li J, Weinberg MS, Zerbini L, Prince S. The oncogenic TBX3 is a
downstream target and mediator of the TGF-β1 signaling pathway.
Mol Biol Cell 2013; 24: 3569-76.
 Du YB, Dong B, Shen LY, Yan WP, Dai L, Xiong HC, Liang Z, Kang XZ,
Qin B, Chen KN. The survival predictive significance of HOXC6 and
HOXC8 in esophageal squamous cell carcinoma. J Surg Res 2014;
 Zhang Q, Jin XS, Yang ZY, Wei M, Liu BY, Gu QL. Upregulated Hoxc6
expression is associated with poor survival in gastric cancer
patients. Neoplasma 2013; 60: 439-45.
 Tamura M, Sasaki Y, Koyama R, Takeda K, Idogawa M, Tokino T.
Forkhead transcription factor FOXF1 is a novel target gene of the
p53 family and regulates cancer cell migration and invasiveness.
Oncogene. 2014; 33: 4837-46.
 Wei S, Wang H, Lu C, Malmut S, Zhang J, Ren S, Yu G, Wang W,
Tang DD and Yan C. The activating transcription factor 3 protein
suppresses the oncogenic function of mutant p53 proteins. J Biol
Chem 2014; 289: 8947-59.
 Feng J, Sun Q, Wu T, Lu J, Qu L, Sun Y, Tian L, Zhang B, Li D, Liu M.
Upregulation of ATF-3 is correlated with prognosis and proliferation
of laryngeal cancer by regulating Cyclin D1 expression. Int J Clin Exp
Pathol 2013; 6: 2064-70.
 Sato A, Nakama K, Watanabe H, Satake A, Yamamoto A, Omi T,
Hiramoto A, Masutani M, Wataya Y, Kim HS. Role of activating
transcription factor 3 protein ATF3 in necrosis and apoptosis
induced by 5-fluoro-2’-deoxyuridine. FEBS J 2014; 281: 1892-900.
 Ahmad A, Ahmad S, Malcolm KC, Miller SM, Hendry-Hofer T,
Schaack JB, White CW. Differential regulation of pulmonary vascular
cell growth by hypoxia-inducible transcription factor-1alpha and
hypoxia-inducible transcription factor-2alpha. Am J Respir Cell Mol
Biol 2013; 49: 78-85.
 Bangoura G, Yang LY, Huang GW, Wang W. Expression of HIF-2alpha/
EPAS1 in hepatocellular carcinoma. World J Gastroenterol 2004; 10:
 Sasai K, Akagi T, Aoyanagi E, Tabu K, Kaneko S, Tanaka S.
O6-methylguanine-DNA methyltransferase is downregulated in
transformed astrocyte cells: implications for anti-glioma therapies.
Mol Cancer 2007, 6: 36.
 Minchenko DO, Danilovskyi SV, Kryvdiuk IV, Bakalets TV, Lypova
NM, Karbovskyi LL, Minchenko OH. Inhibition of ERN1 modifies the
hypoxic regulation of the expression of TP53-related genes in U87
glioma cells. Endoplasmic Reticulum Stress in Diseases 2014; 1:
 Minchenko DО, Kubajchuk КІ, Ratushna OO, Komisarenko SV,
Minchenko OH. The effect of hypoxia and ischemic condition on the
expression of VEGF genes in glioma U87 cells is dependent from
ERN1 knockdown. Adv Biol Chem 2012; 2: 198-206.
 Minchenko OH, Opentanova IL, Minchenko DO, Ogura T, Esumi
H. Hypoxia induces transcription of 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase 4 gene via hypoxia-inducible factor-
1alpha activation. FEBS Lett 2004; 576: 14-20.
 Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz
A, Karabeg E, Breuss J, Minchenko OH, Mechtcheriakova D,
Hohensinner P, Rychli K, Wojta J, Resink T, Binder BR, Leitinger N.
Oxidized phospholipids stimulate angiogenesis via induction of
VEGF, IL-8, COX-2 and ADAMTS-1 metalloprotease, implicating a
novel role for lipid oxidation in progression and destabilization of
atherosclerotic lesions. Circ Res 2006; 99: 900-8.
 Melboucy-Belkhir S, Pradère P, Tadbiri S, Habib S, Bacrot A, Brayer
S, Mari B, Besnard V, Mailleux AA, Guenther A, Castier Y, Mal H,
Crestani B, Plantier L. Forkhead Box F1 (FOXF1) represses cell
growth, COL1 and ARPC2 expression in lung fibroblasts in vitro. Am J
Physiol Lung Cell Mol Physiol. 2014; 307: L838-47.
 Backer MV, Backer JM, Chinnaiyan P. Targeting the unfolded protein
response in cancer therapy. Methods Enzymol. 2011; 491: 37–56.
 Lee AS. GRP78 induction in cancer: therapeutic and prognostic
implications. Cancer Res. 2007; 67: 3496–9.
 Johnson GG, White MC, Grimaldi M. Stressed to death: targeting
endoplasmic reticulum stress response induced apoptosis in
gliomas. Curr Pharm Des. 2011; 17: 284-92.
 Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa
H. Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated
in human oral squamous cell carcinoma. Int J Cancer. 2004;
 White MC, Johnson GG, Zhang W, Hobrath JV, Piazza GA, Grimaldi
M. Sulindac sulfide inhibits sarcoendoplasmic reticulum Ca(2+)
ATPase, induces endoplasmic reticulum stress response, and
exerts toxicity in glioma cells: Relevant similarities to and important
differences from celecoxib. J Neurosci Res. 2013; 91: 393-406. Int J
Cancer. 2004; 110: 225-31.